Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.54 |
| ▸ | PPARD | Q03181 | 1/20 | 0.54 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.54 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.54 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | MTOR | P42345 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29021939 | 1.00 | LCK (0.54) | LCKPPARDZDHHC20ZDHHC2GPR84 | |
| SCHEMBL28639946 | 1.00 | LCK (0.54) | LCKPPARDZDHHC20ZDHHC2GPR84 | |
| SCHEMBL28443444 | 1.00 | LCK (0.54) | LCKPPARDZDHHC20ZDHHC2GPR84 | |
| SCHEMBL2934539 | 1.00 | LCK (0.54) | LCKPPARDZDHHC20ZDHHC2GPR84 | |
| SCHEMBL28655998 | 1.00 | LCK (0.54) | LCKPPARDZDHHC20ZDHHC2GPR84 | |
| SCHEMBL1816629 | 1.00 | LCK (0.54) | LCKPPARDZDHHC20ZDHHC2GPR84 | |
| SCHEMBL4282937 | 1.00 | LCK (0.54) | LCKPPARDZDHHC20ZDHHC2GPR84 | |
| SCHEMBL5888663 | 1.00 | LCK (0.54) | LCKPPARDZDHHC20ZDHHC2GPR84 | |
| SCHEMBL6141035 | 1.00 | — | — | |
| SCHEMBL9158434 | 1.00 | LCK (0.54) | LCKPPARDZDHHC20ZDHHC2GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114831894-A | NMN-containing oxidation-sensitive nano-particle and preparation method and application thereof | 广西萌大夫生物技术有限公司 | 2022-08-02 | — | — | CN | claimed |
| CN-113036217-B | Silicotungstic acid-inner salt end-capped polystyrene hybrid electrolyte material and preparation method thereof | 吉林大学 | 2022-04-01 | — | — | CN | claimed |
| CN-110192511-A | A kind of moisturizing Flower nutrient soil and preparation method thereof | 陈国高 | 2019-09-03 | — | — | CN | claimed |
| CN-110041264-A | A kind of adamantyl glyoxaline ion liquid and preparation method thereof | 贺州学院 | 2019-07-23 | — | — | CN | claimed |
| CN-109879765-A | A kind of quaternary ammonium salt ionic liquid and preparation method thereof containing adamantane | 贺州学院 | 2019-06-14 | — | — | CN | claimed |
| CN-109608648-A | A kind of polyimide material and preparation method thereof with temperature response performance | 太原理工大学 | 2019-04-12 | — | — | CN | claimed |
| CN-106632909-B | A method of reducing polystyrene melt viscosity | 吉林大学 | 2018-11-20 | — | — | CN | claimed |
| CN-105802381-A | Durable interior wall paint | 青岛锦涟鑫商贸有限公司 | 2016-07-27 | — | — | CN | claimed |
| CN-105452224-A | Multifunctional quinoline derivatives as anti-neurodegenerative agents | ANNJI PHARM CO LTD | 2016-03-30 | — | — | CN | claimed |
| CN-105385263-A | Durable interior wall coating and preparation method thereof | XIN FANFAN | 2016-03-09 | — | — | CN | claimed |
| US-12570804-B2 | Supramolecular biomedical polymers | SUPRAPOLIX B.V. (NL) | 2026-03-10 | — | — | US | disclosed |
| CN-116148366-B | Protein complex in-situ analysis method based on active oxygen response carrier | 中国科学院大连化学物理研究所 | 2024-12-10 | — | — | CN | disclosed |
| CN-111971293-B | Peptide synthesis method | JITSUBO株式会社 | 2024-07-30 | — | — | CN | disclosed |
| US-20240110015-A1 | SUPRAMOLECULAR BIOMEDICAL POLYMERS | SUPRAPOLIX B.V. (NL) | 2024-04-04 | — | — | US | disclosed |
| US-11884781-B2 | Supramolecular biomedical polymers | SUPRAPOLIX B.V. (NL) | 2024-01-30 | — | — | US | disclosed |
| WO-1998022516-A1 | BIOCOMPATIBLE COMPOSITIONS | BIOCOMPATIBLES LIMITED (GB) | 1998-05-28 | — | — | WO | disclosed |
| EP-0830440-A1 | LIQUID-CRYSTALLINE POLYMER MATERIAL | Lagerwall, Sven Yngve Torbjörn (SE) | 1998-03-25 | — | — | EP | disclosed |
| WO-1997049671-A1 | METAL-CONTAINING SIDE CHAIN LIQUID CRYSTAL POLYMERS | THE SECRETARY OF STATE FOR DEFENCE (GB) | 1997-12-31 | — | — | WO | disclosed |
| WO-1996024648-A1 | LIQUID-CRYSTALLINE POLYMER MATERIAL | LAGERWALL SVEN TORBJOERN (SE) | 1996-08-15 | — | — | WO | disclosed |
| EP-0168950-B1 | LEUKOTRIENE ANTAGONISTS | SMITHKLINE BECKMAN CORPORATION (US) | 1989-01-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570804-B2 | Supramolecular biomedical polymers | FGB, BMP1, F2 | LCK 4489/4885PPARD 4263/4885ZDHHC20 4150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.